AXIM Biotechnologies (AXIM) 10-Q2018 Q1 Quarterly report

Filed: 15 May 18, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. freshman Avg

New words: accessed, Addiction, allocate, allocating, approach, Asia, attached, attract, Basel, Boelewerf, breach, broadly, call, cGMP, chill, condensedconsolidatedfinancial, confidential, consecutive, consummated, context, copy, core, Cory, currency, daily, depict, description, document, dollar, dry, DWAC, enjoy, entirety, EUR, Exhibit, eye, FINRA, Foreign, furnish, furnished, glaucoma, halted, harbor, historical, initially, LLP, mechanism, navigating, Netherland, Neuralgia, occurrence, ongoing, predecessor, principle, Procopio, proxy, quantified, request, retain, Ridderkerk, room, safe, Savitch, secret, short, size, stop, supplement, suspended, text, undue, VD, viii, volatility, volume, warehouse, website

Removed: abroad, abuse, afer, agree, Almere, amino, animal, arise, arrangement, art, assignment, assured, box, building, carbon, category, CBG, China, collectability, commonly, compelling, competing, competitive, compliant, concrete, condensedconsolidated, construct, corn, cotton, cultivate, decided, decrease, deem, deriving, difficult, ease, easy, essential, exempted, exist, expansion, expiration, expiring, facility, factory, featuring, feed, fifteen, Flevoland, food, foremost, forfeited, fuel, germination, GLP, GMP, granted, greatest, import, importer, impossible, inaccurate, incapable, industrialized, inside, integration, ISO, Kingdom, laboratory, land, letter, light, manufacturing, moratorium, municipality, nonprovisional, notify, nutriceutical, outlined, partially, person, persuasive, plant, predict, predictable, print, processing, profitability, prove, psychotropic, reach, recreational, refund, replaced, representation, responsibly, sativa, Schedule, seek, shipment, slightly, source, square, storage, structure, studied, surface, tetrahydrocannabinol, today, transferable, understand, unknown, variety, vertical, virtually, world, worth, wrote, zone

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

AXIM similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Axim Biotechnologies, Inc., a Nevada corporation, (the “Registrant”) on Form 10-Q for the Quarter ended March 31, 2018 (the “Report”), I, Dr. George Anastassov, Chief Executive Officer of the Registrant, do hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)the Report, as filed with the Securities and Exchange Commission, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

Dated: May 15, 2018

By:

/s/ Dr. George Anastassov

Dr. George Anastassov

Chief Executive Officer

(Principal Executive Officer)